{
    "title": "Clene's ALS drug shows reduction in disease indicator levels in trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12200555/Clenes-ALS-drug-shows-reduction-disease-indicator-mid-stage-trial.html",
    "date": "2023-06-15",
    "keywords": [
        "drug",
        "protein",
        "disease",
        "clene",
        "thursday",
        "reduction",
        "death",
        "approval",
        "june",
        "sclerosis",
        "indicator",
        "progression",
        "midstage",
        "trial",
        "company",
        "neurofilament",
        "placebo",
        "treatment",
        "marker",
        "nerve",
        "cell",
        "degeneration",
        "predictor",
        "decline",
        "function",
        "risk",
        "food",
        "administration",
        "biogen",
        "effectiveness",
        "market",
        "fda",
        "possibility",
        "marketing",
        "application",
        "health",
        "regulator",
        "lou",
        "brain",
        "cord",
        "paralysis",
        "government",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}